Alfred J Novak insider trades

Open-market stock purchases and sales by Alfred J Novak, Director at Pasithea Therapeutics Corp, from SEC Form 4 filings since Jun 15, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +74%.

Recent trades

DateStockTradeValue
May 1, 2026KTTA Pasithea Therapeutics CorpBought (not open market)—
Oct 24, 2025KTTA Pasithea Therapeutics CorpBought (not open market)—

Companies traded

  • KTTA Pasithea Therapeutics Corp: other filings, last May 1, 2026
  • LIVN LivaNova plc: 1 buy, 9 sales, last Jun 15, 2022
  • DOVA Dova Pharmaceuticals Inc: other filings, last Nov 12, 2019
  • CYBX Cyberonics Inc: 5 sales, last Oct 19, 2015

Get free alerts when Alfred J Novak files a new trade →